HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Communication Aids for Disabled (TDD)

Equipment that provides mentally or physically disabled persons with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code, and pictures.
Also Known As:
TDD; Speech Synthesizers; Communication Board; Speech Synthesizer; Telecommunications Devices for the Deaf; TTY Telephone; Text Telecommunication; Text Telecommunication Devices; Text Telephone; Synthesizer, Speech; Synthesizers, Speech; TTY Telephones; Telecommunication Device, Text; Telecommunication Devices, Text; Telecommunication, Text; Telecommunications, Text; Text Telecommunication Device; Text Telecommunications; Text Telephones; Augmentative and Alternative Communications Systems; Communication Aids for Handicapped; Communication Boards
Networked: 219 relevant articles (17 outcomes, 19 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1. Ge, Rui: 3 articles (04/2022 - 08/2015)
2. Kuroda, Akio: 3 articles (02/2022 - 11/2012)
3. Matsuhisa, Munehide: 3 articles (02/2022 - 11/2012)
4. Gellerman, Gary: 3 articles (01/2022 - 10/2019)
5. Nwosu, Benjamin Udoka: 3 articles (08/2017 - 01/2014)
6. Golden, Sherita Hill: 3 articles (05/2017 - 04/2014)
7. Li, Na: 2 articles (10/2022 - 01/2018)
8. Feng, Xiue: 2 articles (04/2022 - 08/2015)
9. Li, Qingshan: 2 articles (04/2022 - 08/2015)
10. Endo, Itsuro: 2 articles (02/2022 - 11/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Type 2 Diabetes Mellitus (MODY)
3. Body Weight (Weight, Body)
4. Pain (Aches)
01/01/2014 - "All the subjects performed the exercise treadmill test, according to the Gardner protocol, at the beginning of the study, after 12 weeks and after 24 weeks, at the end of the study and were measured: the time to pain onset (TDC) and the time to maximum pain onset (maximum walking time=TDD). "
01/01/2023 - "Furthermore, TDD hazard ratios numerically favored T-DXd over T-DM1 in all prespecified variables of interest including pain, suggesting T-DXd may delay time until health-related QoL deterioration compared with T-DM1. "
01/01/2022 - "Similarly, there were no statistically significant differences between groups in outcomes at 12 months: >50% reduction in NRS leg pain (PDD vs. TDD)=51% (95% CI 41%-60%) versus 40% (95% CI: 30%-49%); >30% ODI improvement (PDD vs. TDD)=42% (95% CI 32%-51%) versus 30% (95% CI: 21%-39%). "
01/01/2022 - "When using an intention to treat analysis with those lost to follow-up and requiring a second procedure counting as failures, there were no statistically significant difference between the two treatment groups in the primary and secondary outcomes at 6 months: >50% reduction in NRS leg pain (PDD vs. TDD)=67% versus 65%; >30% ODI improvement (PDD vs. TDD)=57% versus 55%. "
10/01/2021 - "Registry data from the 4646 patients (59.7% female) treated with TDD for chronic, nonmalignant pain at 59 registry sites between August 2003 and October 2019, with over 17,000 patient-years (4646 patients with 44 months average follow-up), were analyzed. "
5. Hypoglycemia (Reactive Hypoglycemia)

Related Drugs and Biologics

1. Insulin (Novolin)
2. Dichlorodiphenyldichloroethane (DDD)
3. Hemoglobins (Hemoglobin)
4. Ethiodized Oil (Ethiodol)
5. Glucose (Dextrose)
6. Long-Acting Insulin (Insulin, Long Acting)
7. Metformin (Glucophage)
8. Liraglutide
9. Short-Acting Insulin
10. Glucagon (Glukagon)

Related Therapies and Procedures

1. Decompression
2. Therapeutics
3. Electrocoagulation (Electrocautery)
4. Peritoneal Dialysis
5. Ligation